Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026 and Aug 2026.
- Largest single sale: $625K (5,000 shares) of Gilead Sciences on Nov 28, 2025. Filing
- Last sale before this period: Jul 14, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Gilead Sciences (GILD) | Director | Dec 10, 2020 | Aug 21, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 20, 2026, Gilead Sciences: sold 5,000 shares for $725K, under a disclosed plan; 4,665 shares vested or acquired by exercising options; 335 shares acquired by exercising options. 1 filing: 1
- Apr 30, 2026, Gilead Sciences: 1,146 shares granted. 1 filing: 1
- Jan 20, 2026, Gilead Sciences: sold 5,000 shares for $618K, under a disclosed plan; 5,000 shares acquired by exercising options. 1 filing: 1
- Nov 28, 2025, Gilead Sciences: sold 5,000 shares for $625K, no plan disclosed; 5,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.